(Press-News.org) Recently, doctors have begun to categorize breast cancers into four main groups according to the genetic makeup of the cancer cells. Which category a cancer falls into generally determines the best method of treatment.
But cancers in one of the four groups — called "basal-like" or "triple-negative" breast cancer (TNBC) — have been particularly tricky to treat because they usually don't respond to the "receptor-targeted" treatments that are often effective in treating other types of breast cancer. TNBC tends to be more aggressive than the other types and more likely to recur, and can also have a higher mortality rate.
Fortunately, better drug therapies may be on the horizon. UCLA researchers and collaborators led by Dean Ho, a professor at the UCLA School of Dentistry and co-director of the school's Jane and Jerry Weintraub Center for Reconstructive Biotechnology, have developed a potentially more effective treatment for TNBC that uses nanoscale, diamond-like particles called nanodiamonds.
Nanodiamonds are between 4 and 6 nanometers in diameter and are shaped like tiny soccer balls. Byproducts of conventional mining and refining operations, the particles can form clusters following drug binding and have the ability to precisely deliver cancer drugs to tumors, significantly improving the drugs' desired effect. In the UCLA study, the nanodiamond delivery system has been able to home in on tumor masses in mice with triple negative breast cancer.
Findings from the study are published online April 15 in the peer-reviewed journal Advanced Materials.
"This study demonstrates the versatility of the nanodiamond as a targeted drug-delivery agent to a tumor site," said Ho, who is also a member of the California NanoSystems Institute at UCLA, UCLA's Jonsson Comprehensive Cancer Center and the UCLA Department of Bioengineering. "The agent we've developed reduces the toxic side effects that are associated with treatment and mediates significant reductions in tumor size."
The team combined several important cancer-fighting components on the nanodiamond surface, including Epirubicin, a highly toxic but widely used chemotherapy drug that is often administered in combination with other cancer drugs. The new compound was then bound to a cell-membrane material coated with antibodies that were targeted toward the epidermal growth factor receptor, which is highly concentrated on the surfaces of TNBC cells. The resulting agent is a drug-delivery system called a nanodiamond-lipid hybrid compound, or NDLP.
When tested on mice, the agent was shown to notably decrease tumor growth and eliminate the devastating side effects of cancer treatment.
Because of its toxicity, Epirubicin, when administered alone can cause serious side effects, such as heart failure and reduced white blood cell count, and it has been linked to an increased risk for leukemia. In the study, all of the mice that were given Epirubicin alone died well before the completion of the study. But all the mice given Epirubicin through the targeted NDLPs survived the treatment, and some of the tumors even regressed until they were no longer visible.
"Triple-negative breast cancer is often very aggressive and hard to treat, making aggressive chemotherapy a requirement," said Dr. Edward K. Chow, co-first author of the study and an assistant professor at the Cancer Science Institute of Singapore. "The targeting and therapeutic efficiency of the nanodiamond-lipid agents were quite remarkable. The simultaneous tumor regression and improved drug tolerance are promising indicators for the continued development of the nanodiamonds toward clinical translation."
The research team is now studying the efficacy and safety of the NDLPs in larger animals. Additional research objectives include determining whether nanodiamonds can enhance the tolerance of a wide spectrum of highly toxic drug compounds, which may improve current treatment options and outcomes. These discoveries will serve as precursors for human trials, the researchers said.
"The nanodiamond-lipid hybrid developed in this study is a modular platform," said Laura Moore, a graduate student in Ho's laboratory and a co-first author of the study. "Therefore, we can easily bind a wide spectrum of targeting antibodies and drug compounds to address several diseases."
Dr. No-Hee Park, dean of the UCLA School of Dentistry, noted that the research will provide a foundation for future clinical applications.
"This pioneering study conducted by Dean Ho and his team provides a better understanding of the capabilities of the nanodiamond material to address several diseases," Park said. "Their work is of paramount importance."
INFORMATION:
Other authors of the study were Professor Eiji Osawa of the NanoCarbon Research Institute in Nagano, Japan, and Professor J. Michael Bishop of UC San Francisco. Laura Moore is currently at Northwestern University.
The study was supported by the National Cancer Institute, the National Science Foundation, the Wallace H. Coulter Foundation, the V Foundation for Cancer Research, the Society for Laboratory Automation and Screening, the George Williams Hooper Foundation, the American Cancer Society, Beckman Coulter, the European Commission, the Cancer Science Institute of Singapore, and the Singapore Ministry of Education Academic Research Fund.
The UCLA School of Dentistry is dedicated to improving the oral and systemic health of the people of California, the nation and the world through its teaching, research, patient care and public service initiatives. The School of Dentistry provides education and training programs that develop leaders in dental education, research, the profession and the community. The School of Dentistry also conducts research programs that generate new knowledge, promote oral health and investigate the cause, prevention, diagnosis and treatment of oral disease in an individualized disease-prevention and management model; and delivers patient-centered oral health care to the community and the state.
For more news, visit the UCLA Newsroom and follow us on Twitter.
END
ANN ARBOR—The larger the group, the smaller the chance of forming interracial friendships, a new University of Michigan study shows.
Published in the Proceedings of the National Academy of Sciences, the study examines how the size of a community affects the realization of people's preferences for friends. U-M researchers Siwei Cheng and Yu Xie tested their theoretical model using both simulated and real data on actual friendships among 4,745 U.S. high school students.
"We found that total school size had a major effect on the likelihood that students would form interracial ...
Writers: Emil Venere, (765) 494-4709, venere@purdue.edu
Sources: Ji Soo Yi, 765-496-7213, yij@purdue.edu
Bum chul Kwon, kwonb@purdue.edu
Related Web site:
Ji Soo Yi: http://web.ics.purdue.edu/~yij/
PHOTO CAPTION:
Purdue industrial engineering doctoral candidate Bum chul Kwon demonstrates a new system that allows treadmill users to read while they run. The system, called ReadingMate, adjusts text on a monitor to counteract the bobbing motion of a runner's head so that the text appears still. (Purdue University photo/Mark Simons)
A publication-quality ...
Researchers from Chulalongkorn University, Bangkok and the Natural History Museum, London (Thanit Siriboon, Chirasak Sutcharit, Fred Naggs and Somsak Panha) discovered many new taxa of the brightly coloured carnivorous terrestrial snails family Streptaxidae. Terrestrial snails are primarily herbivores and only a rare few groups like this one are carnivorous. The animals come from several limestone areas across the world, including some threatened by human exploitation, especially by quarrying.
Three new species from the genus Perrottetia were described from north and ...
INDIANAPOLIS and WEST LAFAYETTE, Ind. -- Information collected from individual patients at doctor's office and hospital visits could be used to improve health care and reduce costs on a national scale, according to a discussion paper released by the Institute of Medicine.
As health care records move to electronic systems, there is an opportunity to compile information taken from individuals and use it to conduct large studies that advance the entire health care system, said Michael D. Murray, PharmD, MPH, the Regenstrief Institute investigator and Purdue University professor ...
How do nerve cells -- which can each be up to three feet long in humans -- keep from rupturing or falling apart?
Axons, the long, cable-like projections on neurons, are made stronger by a unique modification of the common molecular building block of the cell skeleton. The finding, which may help guide the search for treatments for neurodegenerative diseases, was reported in the April 10 issue of Neuron by researchers at the University of Illinois at Chicago College of Medicine.
Microtubules are long, hollow cylinders that are a component of the cytoskeleton in all cells ...
COLUMBIA, Mo. – People with an Autism Spectrum Disorder (ASD) often have trouble communicating and interacting with others because they process language, facial expressions and social cues differently. Previously, researchers found that propranolol, a drug commonly used to treat high blood pressure, anxiety and panic, could improve the language abilities and social functioning of people with an ASD. Now, University of Missouri investigators say the prescription drug also could help improve the working memory abilities of individuals with autism.
Working memory represents ...
April 15, 2013 – San Francisco - A brain-training task that increases the number of items an individual can remember over a short period of time may boost performance in other problem-solving tasks by enhancing communication between different brain areas. The new study being presented this week in San Francisco is one of a growing number of experiments on how working-memory training can measurably improve a range of skills – from multiplying in your head to reading a complex paragraph.
"Working memory is believed to be a core cognitive function on which many types of ...
AURORA, Colo. (April 15, 2013) – A newly published study of patients with pulmonary fibrosis has discovered multiple genetic variations that should help with future efforts to treat the disease.
Pulmonary fibrosis is a condition where lung tissue becomes thickened, stiff and scarred. Currently in the United States, there are no drugs approved for use in cases of the condition's most common and severe form, which is known as idiopathic pulmonary fibrosis (IPF) because the cause of the disease is not known. In those cases, the median survival time after diagnosis is two ...
As small and active flying mammals, bats have very high mass-specific energy requirements and as such continually adjust their rates of activity and metabolism in response to ambient temperature and other seasonal variation. In particular, during the autumn mating season, male bats must carefully balance time spent foraging (to gain enough fat to last the winter hibernation) with time spent finding a mate. Because both activities require significant effort, how do male bats do it? In an upcoming issue of Physiological and Biochemical Zoology, Nina Becker and colleagues ...
Specific DNA once dismissed as junk plays an important role in brain development and might be involved in several devastating neurological diseases, UC San Francisco scientists have found.
Their discovery in mice is likely to further fuel a recent scramble by researchers to identify roles for long-neglected bits of DNA within the genomes of mice and humans alike.
While researchers have been busy exploring the roles of proteins encoded by the genes identified in various genome projects, most DNA is not in genes. This so-called junk DNA has largely been pushed aside ...
